Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20434449 | 1.00 | ALK (0.33) | ALK | |
| SCHEMBL21094688 | 0.96 | ALK (0.32) | ALK | |
| SCHEMBL20832391 | 0.95 | ALK (0.35) | ALK | |
| SCHEMBL19163548 | 0.94 | ALK (0.31) | ALK | |
| SCHEMBL19001800 | 0.94 | ALK (0.31) | ALK | |
| SCHEMBL20832282 | 0.94 | ALK (0.33) | ALK | |
| SCHEMBL19167276 | 0.94 | ALK (0.33) | ALK | |
| SCHEMBL19165486 | 0.94 | ALK (0.33) | ALK | |
| SCHEMBL19395253 | 0.93 | ALK (0.32) | ALK | |
| SCHEMBL22680162 | 0.93 | ALK (0.34) | ALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10431751-B2 | Compound and organic electronic device comprising the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2019-10-01 | — | — | US | disclosed |
| US-20170213970-A1 | Novel compound and organic electronic device comprising the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2017-07-27 | — | — | US | disclosed |
| US-20170213970-A1 | Novel compound and organic electronic device comprising the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10431751-B2 | Compound and organic electronic device comprising the same | CHRM1, CHRM2, ESR1 | ALK 596/4885 |
| US-20170213970-A1 | Novel compound and organic electronic device comprising the same | CHRM1, CHRM2, ESR1 | ALK 657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.